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Abstract
Background: Compared to lobectomy by video-assisted thoracic surgery (VATS), segmentectomy by VATS has a
potential higher risk of postoperative atelectasis and air leakage. We compared postoperative complications between
these two procedures, and analyzed their risk factors.
Methods: We reviewed the records of all patients who underwent anatomical pulmonary resections by VATS from
January 2014 to March 2018 in two Swiss university hospitals. All complications were reported. A logistic regression
model was used to compare the risks of complications for the two interventions. Adjustment for patient characteristics
was performed using a propensity score, and by including risk factors separately.
Results: Among 690 patients reviewed, the major indication for lung resection was primary lung cancer (86.4%) followed
by metastasis resection (5.8%), benign lesion (3.9%), infection (3.2%) and emphysema (0.7%). Postoperatively, there were
80 instances (33.3%) of complications in 240 segmentectomies, and 171 instances (38.0%) of complications in
450 lobectomies (P = 0.73). After adjustment for the patient’s propensity to be treated by segmentectomy rather than
lobectomy, the risks of a complication remained comparable for the two techniques (odds ratio for segmentectomy
0.91 (0.61–1.30), p = 0.59). Length of hospital stay and drainage duration were shorter after segmentectomy.
On multivariate analysis, an American Society of Anesthesiologists score above 2 and a forced expiratory volume in one
second below 80% of predicted value were significantly associated with the occurrence of complications.
Conclusions: The rate of complications and their grade were similar between segmentectomy and lobectomy by VATS.
Keywords: Complication, Segmentectomy, Lobectomy, Video-assisted thoracic surgery
Background
Currently, pulmonary lobectomy is routinely performed
by video-assisted thoracic surgery (VATS) for several in-
dications. In patients with lung cancer, VATS lobectomy
is considered safe and effective in early stage non-small
cell lung cancer (NSCLC) [1–3]. Furthermore, compared
to open lobectomy, the VATS approach is associated
with less postoperative pain and better quality of life [4].
In parallel, VATS segmentectomy is increasingly pro-
posed as an alternative to lobectomy to spare pulmonary
parenchyma for benign and malignant lesions. In
patients with NSCLC, segmentectomy seems to ensure
equivalent oncological outcomes for tumor sizes smaller
than 2 cm without nodal involvement [5, 6].
Evidence of functional benefit of segmentectomy over
lobectomy remains low with debatable results, but the
former seems to better preserve lung function via an
increased function of the ipsilateral non-operated lobe
[7, 8]. However, the segmentectomy procedure requires
more extensive and deeper dissection into the hilum and
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division of the intersegmental plane, which may lead to
an higher rate of prolonged air leaks [9]. Furthermore,
the use of staplers to divide the intersegmental plane can
induce compression of the adjacent lung and may cause
atelectasis and pneumonia of the remnant lobe. Few
studies that reported incidence and severity of postoper-
ative complications following segmentectomy and lobec-
tomy by VATS, and other retrospective studies that have
yielded contradictory results and had study limitations
(e.g., small sample or single-center cohort; incomplete
data about complications; analysis of patients with early-
stage cancer; lack of analysis of predictive factors for
complications) [9–13].
The aim of this study was to compare the incidence of
post-operative complications between VATS segmen-
tectomy and VATS lobectomy and to identify their pre-
dictive factors.
Methods
Patients
We reviewed the records of all patients who underwent
anatomical pulmonary resections by VATS from January
2014 to March 2018 at the University Hospitals of
Lausanne and Geneva in Switzerland. The local ethics
committee approved this study (referral number: 2018–
00179) and waived the need to obtain informed patient
consent. All indications were included. All patients with
NSCLC were presented at an interdisciplinary tumour
board. The indication for VATS lobectomy for lung can-
cer was proposed in patients with tumors resectable by a
minimally invasive approach. The indication for VATS
segmentectomy for lung cancer was proposed in patients
with a nodule smaller than 2 cm without nodal involve-
ment. VATS segmentectomy have been performed
“intentionally”, unrelated to the fitness of the patient.
Surgical technique
Four surgeons who had each performed > 100 cases of
VATS lobectomy included in this study carried out all
segmentectomies. Surgical resections were undertaken
using an anterior three-port approach. All vascular
structures were transected using endoscopic staplers or
an energy device and complete dissection of hilar and
mediastinal lymph nodes was carried out in patients
with NSCLC. All bronchial structures were transected
using endoscopic staplers. In segmentectomy, the inter-
segmental plane was divided using staplers. In lobectomy,
a fissure-less technique was performed preferentially.
Classification of postoperative complications
Patient records were extracted from the hospital data
management system. The following data were obtained:
patient demographics and comorbidities; preoperative
lung function; indication for surgery; type of pulmonary
resection; duration of surgery; histologic findings; dur-
ation of drainage; length of hospital stay (LOS); postop-
erative complications and mortality.
The primary endpoint was the occurrence of the fol-
lowing cardiopulmonary complications: atrial fibrillation;
acute myocardial ischemia; pneumothorax; hemothorax;
prolonged air leak (PAL), defined as an air leak lasting
beyond postoperative day 7; acute respiratory distress
syndrome (ARDS), defined using the Berlin classification
[14]; pneumonia, defined by the need for antibiotics
according to the appearance of new lung infiltrate at
chest-X rays, fever, or an elevated white blood cell count
> 12,000 per ml; acute pulmonary edema; massive sub-
cutaneous emphysema; atelectasis; pulmonary embolism;
chylothorax; cardiac infarction; empyema; bronchopul-
monary fistula.
The secondary endpoint was the occurrence of any
other complication, such as recurrent and phrenic nerve
injury, gastrointestinal ileus, colitis, gastroparesis, upper
gastrointestinal bleeding, septic shock and acute renal
failure.
The complications were then classified in 3 groups ac-
cording to the Thoracic Morbidity and Mortality system:
[15] Minor complications (grade I and II), major compli-
cations (grade III and IV) and mortality (grade V). For
patients experiencing more than one complication, the
most severe grade was assigned.
Statistical analysis
For patient characteristics, chi-squared or Fischer’s exact
tests were used to analyze categorical variables. A T-test
or Mann-Whitney U test was used to analyze continuous
variables.
Since patients were assigned to lobectomy or segmen-
tectomy based on their clinical characteristics (and not at
random), the comparison of complication rates required
adjustment for potential confounders. A propensity score
was calculated from a logistic regression model, including
following variables: gender, the presence of chronic
obstructive pulmonary disease (COPD), indication for
surgery (primary lung cancer, metastasis, benign lesion,
emphysema, infection), and location of the lesion (lobe).
This model represented the probability of being assigned
to VATS segmentectomy as opposed to VATS lobectomy.
A Nagelkerke R [2] test was used to measure the
goodness-of-fit and the area under the curve was used to
measure propensity-score performance. A logistic regres-
sion analysis was used with the propensity-score model
and the type of intervention to assess the occurrence of
complications. We compared the distributions of propen-
sity scores in patients treated with segmentectomy and
lobectomy, and excluded tail distributions that received
only one treatment modality (49 patients with propensity
< 0.10 were all treated with lobectomy, and 6 patients with
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propensity > 0.85 were all treated with segmentectomy).
We then obtained a classic logistic regression model
where the occurrence of any complication was a function
of treatment modality and of the continuous propensity
score (Model 1). To verify the robustness of the result we
also performed a conditional logistic regression analysis,
using 15 matched sets of patients (propensity 0.100–0.149,
0.150–0.199, 0.200–0.249, etc) (Model 2). These analyses
were repeated for cardio-pulmonary complications only.
For the occurrence of any complication, the predictive
factors for complications were also analyzed using a
multivariate logistic regression models. The cutoffs of
the forced expiratory volume in one second (FEV1) and
the diffusing capacity of the lungs for carbon monoxide
(DLCO) predictive values were chosen according to
established recommendations [16].
Results
Patients and surgery
Patients’ demographic and clinical characteristics are
summarized in Table 1. Overall, 690 patients were
reviewed, including 240 who had VATS segmentec-
tomies and 450 who had VATS lobectomies. The
conversion rate to thoracotomy was 5.8% for both proce-
dures. Most interventions were performed in center 1
(62.6%). As shown in Table 1, preoperative patient char-
acteristics were not significatively different regardless the
type of surgery for age, comorbidities and American
Society of Anesthesiologists (ASA) score. The major
indication for lung resection was primary lung cancer
(86.4%) followed by metastasis resection (5.8%), benign
lesion (3.9%), infection (3.2%) and emphysema (0.7%).
The type of surgery differed among indications (Table
1). Patients with primary lung cancer were more likely
to have VATS lobectomy than VATS segmentectomy
(91.1% versus 77.5%, respectively). On the other hand,
resection of metastasis and benign lesions was likely
performed by VATS segmentectomy. The location of the
lung resection differed significantly between the proce-
dures, with an upper right location predominantly found
in the lobectomy group and a left location in the seg-
mentectomy group. Overall, a systematic lymph node
dissection was significantly more often performed during
VATS lobectomy (Table 1). The FEV1 and DLCO did
not differ between procedures.
As shown in Table 2, in patients with primary lung
cancer, larger tumor and nodal involvement were
strongly associated with VATS lobectomy. The duration
of operation and the rate of conversion to thoracotomy
were similar between both groups.
Complications
As shown in Table 2, overall, 33.3% of patients experienced
postoperative complications after VATS segmentectomies
and 38% after VATS lobectomies. Most patients had only
one complication and the average number of complications
per patient was not significantly different between segmen-
tectomy and lobectomy. The reoperation rate was not
significantly different for the two procedures. VATS sleeve
lobectomy was performed in 14 patients, 50% of whom had
cardiopulmonary complications. Upper bilobectomy was
performed in 11 patients, 54% of whom had cardiopulmo-
nary complications. According to the TMM system, the
grade of complications was comparable between both
procedures (Table 2). After VATS segmentectomy and
VATS lobectomy, minor complications occurred in 25.4
and 29.1% of patients, respectively, major complications in
7.1 and 8.4% of patients, and death in 0.8 and 0.4% of
patients. Furthermore, the type of procedure was not asso-
ciated with any specific complication, especially prolonged
air leak, atelectasis or bronchopneumonia (Table 2). The
results were similar when we analyzed complications in
patients with lung cancer (data not shown).
The logistic regression model to construct the propen-
sity score is shown in Additional file 1 and included
gender, presence of COPD, histology, and location of the
resection. The comparison of propensity score between
interventions is shown in Additional file 2, with a favor-
able AUC of 0.744 (CI 95% 0.706–0.782). According to
this propensity score, we demonstrated that the occur-
rence of any complication or cardiopulmonary complica-
tion was similar between VATS segmentectomy and
VATS lobectomy (Table 3).
Risk factors
The associations between patient characteristics and
complications are shown in Additional file 3. The risk of
complications increased significantly with age and then
decreased in the oldest patients (41.4% in patients be-
tween 70 and 79 years old and 25.4% in patients between
80 and 90 years old). Compared to those with a normal
body mass index, underweight patients had an almost
10% increased risk of complication. However, overweight
or obesity did not seem to impact the risk of complica-
tions. The occurrence of complications was significantly
associated with ASA score > 2, an increased number of
pack years, presence of COPD, a decreased FEV1, and a
decreased DLCO. The risk of complication also depended
on the surgical indication, with a lower risk in patients
with metastasis or benign lesion resection and a higher
risk in patients with lung volume reduction surgery. How-
ever, while the size of the lesion differed between the two
groups, size was unrelated to the occurrence of complica-
tions (mean 26.1 ± 17.2 without complication, 26.9 ± 16.8
with complication, p = 0.55).
In the multivariate analysis, an ASA score above 2,
and a FEV1 below 80% were significantly associated with
the occurrence of complications (Table 4). However,
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benign nodule and metastasis resection, as well as mid-
dle lobe resection were significantly associated with a
better postoperative outcome (Table 4). The ASA score
and the FEV1 were not correlated with TMM grade.
Length of hospital stay
Segmentectomy by VATS was associated with a shorter
duration of drainage than lobectomy by VATS (3 days,
IQR [1–5] versus 2 days, IQR [1–3], respectively, P =
Table 1 Correlations of patient characteristics with type of
intervention by VATS
Characteristics N (%) Segmentectomy
N = 240
Lobectomy
N = 450
P
Center
1 432
(62.6)
143 (59.6) 289 (64.2) 0.23
2 258
(37.4)
97 (40.4) 161 (35.8)
Gender, man 375
(54.3)
116 (48.3) 259 (57.6) 0.02
Age
21–59 168
(24.3)
59 (24.6) 109 (24.2) 0.96
60–69 248
(35.9)
89 (37.1) 159 (35.3)
70–79 215
(31.2)
72 (30.0) 143 (31.8)
80–90 59 (8.6) 20 (8.3) 39 (8.7)
ASA score
1 6 (0.9) 2 (0.8) 4 (0.9) 0.77
2 377
(54.6)
134 (56.1) 243 (54.4)
3 295
(42.8)
99 (41.4) 196 (43.8)
4 8 (1.2) 4 (1.7) 4 (0.9)
BMI (mg/kg2)
14.5–18.4 46 (6.7) 17 (7.1) 29 (6.5) 0.46
18.5–24.9 305
(44.2)
101 (42.2) 204 (45.7)
25–29.9 223
(32.3)
86 (36.1) 137 (30.7)
30.0–57.0 110
(15.9)
34 (14.3) 76 (17.0)
Active smoker 293
(42.5)
91 (37.9) 202 (45.0) 0.07
PY, mean (SD) 35.4
(30)
34.2 (29.6) 36.1 (30.2) 0.46
Arterial
hypertension
345
(48.6)
121 (50.4) 214 (47.6) 0.47
Cardiopathy 88
(12.8)
26 (10.8) 62 (13.8) 0.27
Diabetes 102
(14.8)
31 (12.9) 71 (15.8) 0.30
COPD 259
(37.5)
99 (41.3) 160 (35.6) 0.14
History of cancer 229
(33.2)
93 (38.8) 136 (30.2) 0.02
FEV1 (%), 28 missing
24–59 53 (8.0) 21 (9.1) 32 (7.4) 0.42
Table 1 Correlations of patient characteristics with type of
intervention by VATS (Continued)
Characteristics N (%) Segmentectomy
N = 240
Lobectomy
N = 450
P
60–79 169
(25.5)
64 (27.7) 105 (24.4)
80–170 440
(66.5)
146 (63.2) 294 (68.2)
DLCO (%), 54 missing
26–60 125
(19.7)
49 (22.3) 76 (18.3) 0.48
61–80 238
(37.4)
79 (35.9) 159 (38.2)
81–154 273
(42.9)
92 (41.8) 181 (43.5)
Indication
Lung cancer
(primary)
596
(86.4)
186 (77.5) 410 (91.1) < 0.001
Metastasis 40 (5.8) 27 (11.3) 13 (2.9)
Benign lesion 27 (3.9) 18 (7.5) 9 (2.0)
Emphysema 5 (0.7) 0 (0) 5 (1.1)
Infection 22 (3.2) 9 (3.8) 13 (2.9)
Side, right 375
(54.3)
89 (37.1) 286 (63.6) < 0.001
Location (lobe)
Upper right 198
(28.7)
41 (17.1) 157 (34.9) < 0.001
Middle right 38 (5.5) 2 (0.8) 36 (8.0)
Lower right 128
(18.6)
46 (19.2) 82 (18.2)
2 right lobes 11 (1.6) 0 (0) 11 (2.4)
Upper left 180
(26.1)
76 (31.7) 104 (23.1)
Lower left 135
(19.6)
75 (31.3) 60 (13.3)
SLND 614
(89.0)
203 (84.6) 411 (91.3) 0.01
VATS Video-assisted thoracic surgery, ASA American Society of
Anesthesiologists score, BMI Body mass index, PY pack-year, COPD Chronic
obstructive pulmonary disease, FEV1 Forced expiratory volume in one second,
DLCO Diffusing capacity of the lungs for carbon monoxide, SLND systematic
lymph node dissection
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0.011) and a shorter length of hospital stay (7 days, IQR
[5–11] versus 6 days, IQR [4–9], respectively, P = 0.045).
The length of hospital stay (LOS) increased with the
presence of complication (6.1 ± 3.5 days versus 13.4 ± 11
days, P < 0.001). The LOS was also affected by TMM
degree of complication, with an average of 12.3 ± 8.4
days for patients with minor complications and 17.2 ±
16.3 days for patients with major complications (P =
0.0034).
Discussion
Although complications after lobectomy have been char-
acterized extensively, remarkably little is known about
complications after anatomical resections by VATS. In
this multicenter study, which compared complications
between intentional segmentectomy and lobectomy by
VATS, we have shown that: (i) the risk of complication
after VATS segmentectomy was not significantly differ-
ent than that after VATS lobectomy; (ii) the TMM
scores were comparable between the two procedures;
(iii) a FEV1 below 80% and an ASA score of 3–4 were
associated with an increased risk of complications
(regardless of the procedure); (iv) benign nodule and
metastasis resection, as well as middle lobe resection
were associated with a better postoperative outcome;
and (v) the drainage duration and the LOS were shorter
in the VATS segmentectomy group.
In our study, we have shown that the rate, the type and
the grade of complication were not different between
segmentectomy and lobectomy by VATS. Neither the dis-
section of the intersegmental plane nor the parenchymal
compression during segmentectomy seem to increase the
risk of pulmonary complications. A few retrospective
studies compared postoperative complication rate after
VATS anatomical resections and found contradictory
results [9–13]. Our finding of no difference between
segmentectomy and lobectomy in incidence of cardiopul-
monary complications contrasts with the findings of Deng
et al. [9] This study shown a higher incidence of PAL and
pulmonary complications after VATS segmentectomy.
Table 2 Procedures and postoperative outcomes
Outcomes Segmentectomy
N = 240
Lobectomy
N = 450
P
Patients with cardiopulmonary
complication, N (%)
75 (31.3) 160 (35.6) 0.26
Patients with any complication,
N (%)
80 (33.3) 171 (38.0) 0.22
Complication per patient if
occurs, mean (SD)
1.65 (1.04) 1.67 (1.03) 0.87
TMM, N (%)
Grade 1–2 61 (25.4) 131 (29.1) 0.73
Grade 3–4 17 (7.1) 38 (8.4)
Grade 5 2 (0.8) 2 (0.4)
Type of complications, N (%)
BPN 30 (12.5) 67 (14.9) 0.42
PAL 21 (8.8) 51 (11.3) 0.36
FA 13 (5.4) 39 (8.7) 0.13
Pneumothorax 16 (6.7) 21 (4.7) 0.29
Hemothorax 3 (1.2) 9 (2) 0.56
ARDS 4 (1.7) 4 (0.9) 0.46
Atelectasia 5 (2.1) 14 (3.1) 0.63
Acute pulmonary edema 1 (0.4) 1 (0.2) 1.0
Massive subcutaneous
emphysema
11 (4.6) 21 (4.7) 1.0
Chylothorax 0 (0) 1 (0.2) 1.0
Pulmonary embolism 2 (0.8) 1 (0.2) 0.28
BPF 0 (0) 1 (0.2) 1.0
Empyema 4 (1.7) 2 (0.4) 0.19
Cardiac infarction 0 (0) 3 (0.7) 0.55
Recurrent nerve paralysis 0 (0) 5 (1.1) 0.17
Acute renal failure 5 (2.1) 17 (3.8) 0.26
Septic shock 3 (1.2) 6 (1.3) 1.0
Cardiorespiratory arrest 2 (0.8) 0 (0) 0.12
Ileus 3 (1.2) 2 (0.4) 0.35
Upper GI bleeding 2 (0.8) 0 (0) 0.12
Gastroparesis 1 (0.4) 0 (0) 0.35
Reoperation 6 (2.5) 21 (4.7) 0.22
Duration of surgery, mean (SD) 147.1 (55.2) 150.3 (50.6) 0.44
Conversion 14 (5.8) 26 (5.8) 0.98
Oncological histology, N (%)
NSCLC 170 (90.9) 359 (87.1) 0.055
SCLC 2 (1.1) 7 (1.7)
NET (AC, TC, LNEC) 15 (8) 33 (8)
Other 0 (0) 13 (3.2)
Tumor size (mm), mean (SD) 17.5 (8.1) 30.7 (17.1) <
0.001
Lymph node involvement N = 183 N = 406 0.001
Table 2 Procedures and postoperative outcomes (Continued)
Outcomes Segmentectomy
N = 240
Lobectomy
N = 450
P
pN1 6 (3.3) 39 (9.6)
pN2 10 (5.5) 47 (11.6)
Drainage duration, median [IQR] 2 [1–3] 3 [1–5] 0.012
LOS, median [IQR] 6 [4–9] 7 [5–11] 0.045
SD Standard deviation, NSCLC Non-small cell lung cancer, SCLC Small-cell lung
cancer, NET Neuroendocrine tumor, TC Typical carcinoid, AC Atypical carcinoid,
LNEC Large cell neuroendocrine carcinoma, LOS Length of hospital stay, TMM
Thoracic morbidity and mortality score, BPN Bronchopneumonia, PAL
Prolonged air leak, AF Atrial fibrillation, ARDS Acute respiratory distress
syndrome, BPF Bronchopulmonary fistula, GI gastrointestinal
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Because of their small sample size in the segmentectomy
group (N = 35), the authors suggested that a learning
curve could explain this result. In their comparison of
postoperative complications between segmentectomy
(N = 39) and lobectomy (N = 81), Zhong et al. [12] found
that despite the small sample size, postoperative complica-
tion rates were low and similar (12.8% vs. 12.3%, P = 0.94)
and the most frequent complication was atrial fibrillation
(2.6% vs. 3.7%). However, the patients had few comorbidi-
ties and only 18.9% of patients suffered from COPD. A
study by Whang et al. [11] that included only pulmonary
complications in a match-paired study of 94 segmentec-
tomies and 94 lobectomies reported comparable postoper-
ative pulmonary complication rates of 10.6% for
segmentectomies and 17.2% for lobectomies (P = 0.1); 18%
of patients suffered from COPD. Recently, Song et al.
reported similar rates of postoperative pulmonary compli-
cations (15.3%) between segmentectomy (N = 41) and
lobectomy (N = 122) [10]. Finally, Lin et al. compared
segmentectomy (N = 32) and lobectomy (N = 47) by a
single-port approach, finding no difference in the postop-
erative complication rate (P = 0.19) [13].
Although these studies showed similar results to our
findings, their complication rates appeared lower. How-
ever, they included only patients with early-stage NSCLC
and reported only cardio-pulmonary complications. One
explanation for the higher rate of complications in our
study is that we included all types of complications. We
report postoperative complications routinely and exten-
sively, which could increase the number of complications
[17, 18]. In addition, the higher rate of patient comorbidi-
ties in our study, as compared to some other studies,
could increase the rate of complication, as established in
the European risk models for morbidity (Eurolung1) score
[19]. In this sense, Deng et al. reported a higher rate of
complications after VATS segmentectomy and lobectomy
(68.6% vs. 74.1%), with a comorbidity rate comparable to
our findings. Finally, our higher incidence of pneumonia
in particular could be explained by the higher rate of
comorbidities and patients with COPD.
In our study, predictive factors for complications
include an ASA score > 2 and a FEV1 < 80% of the
predicted value, regardless of the procedure. However,
the ASA score and the FEV1 were not associated with
the TMM grade. The ASA score as a predictive factor
for complication was previously established in the Euro-
lung 1 score [19]. In thoracotomy patients, FEV1 < 60%
has been associated with a higher rate of pulmonary
complications [20, 21]. We also found that FEV1 < 60%
was a predictive factor of post-operative complications
in anatomical resection by VATS. As compared to an
FEV1 above 80%, the risk of complication increased by
60% in patients with an FEV1 under 60% of the
predicted value. Contrary to FEV1, a lower DLCO is not
associated with an increased risk of complication.
Similarly to our findings, Benattia et al. showed that the
FEV1, but not DLCO, independently predicted
Table 3 Logistic regression models for the occurrence of any complication, and of a cardiopulmonary complication
Models Any complication Cardiopulmonary complication
OR (95% CI) P OR (95% CI) P
1 VATS segmentectomya 0.91 (0.61–1.30) 0.58 0.93 (0.65–1.34) 0.71
Propensity scoreb 0.42 (0.16–1.17) 0.10 0.46 (0.19–1.13) 0.049
2 VATS segmentectomya 0.93 (0.70–1.24) 0.62 0.86 (0.60–1.24) 0.41
Model 1: standard logistic regression, where the propensity score was left as a continuous probability between 0 and 1. Model 2: Conditional logistic regression,
with 15 sets matched for propensity (0.100–0.149, 0.150–0.199, 0.200–0.249, etc). Fifty-five patients with a propensity for segmentectomy < 0.10 and > 0.85 were
excluded, as all were treated with the same intervention. a vs lobectomy
b probability of 1 vs 0
VATS Video-assisted thoracic surgery, OR Odds ratio, CI Confidence interval
Table 4 Multivariate model of risk factors for complications
(intervention type was forced into the model)
Risk factors OR (95% CI) P
Segmentectomy (vs lobectomy) by VATS 0.89 (0.62–1.28) 0.74
Center 2 (vs Center 1) 0.71 (0.50–1.01) 0.051
ASA 3–4 (vs 1–2) 1.55 (1.10–2.19) 0.011
FEV1 < 80% (vs ≥80%) 1.61 (1.11–2.30) 0.009
Indication 0.042
Lung cancer (primary) 1 (reference) –
Metastasis 0.32 (0.13–0.80) 0.015
Benign lesion 0.27 (0.08–0.95) 0.042
Emphysema 1.33 (0.21–8.31) 0.76
Infection 0.74 (0.22–2.44) 0.64
Location (lobe) 0.066
Upper (right or left) 1 (reference) –
Middle right 0.32 (0.13–0.82) 0.018
Lower (right or left) 0.96 (0.68–1.36) 0.82
2 right lobes 2.15 (0.58–8.01) 0.25
OR Odds ratio, CI Confidence interval, VATS Video-assisted thoracic surgery,
ASA American Society of Anesthesiologists score, FEV1 Forced expiratory
volume in one second
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postoperative outcome in VATS anatomical resection
[22]. However, another study did not report FEV1 and
DLCO as independent predictor factors for pulmonary
complications after lobectomy by VATS [23]. According
to our results, probably that preoperative risk assessment
recommended by the ERS/ESTS task force to predict
postoperative morbidity after resection by thoracotomy
could be used for all anatomical resections by VATS.
However, further studies are needed to confirm this
hypothesis.
The postoperative complications after anatomical resec-
tion for other indications than NSCLC have not been stud-
ied yet. In our study, resection of metastasis and benign
lesion are associated with a lower risk of postoperative
complication, regardless of the type of resection. A less ex-
tensive dissection during intervention in these indications
could explain our results.
Interestingly, the drainage duration and the LOS was
shorter in VATS segmentectomy than in VATS lobec-
tomy. Furthermore, VATS segmentectomy showed a
similar rate of conversion as VATS lobectomy and could
be considered safe. Further studies are needed to
compare the global costs between the two procedures.
Our study had several limitations. First, it was a retro-
spective analysis of two centers experience in VATS
segmentectomy and lobectomy and may introduce selec-
tion and information bias. Second, the low granularity of
data regarding the management of complications
allowed only a rough classification of the TMM grade.
Third, post-operative management was based on local
practice, which differed between the two centers, al-
though both had similar proportions of VATS segmen-
tectomies and VATS lobectomies. Fourth, data about
VATS segmentectomies included the learning phase of
the technique, which could have influenced the postop-
erative outcomes during the initial phase. We have not
analyzed the difference in complication rates among the
study periods. Fifth, as expected with registered data,
several factors were missing from our data sets, includ-
ing the 90-day mortality and comorbidity scores. For
these reasons, the EuroLung1 EuroLung2 scores could
not be used [19]. Sixth, perioperative data was lacking
regarding the complexity of the procedure and peri-
operative complications. However, the large number of
patients with VATS segmentectomy available for ana-
lysis, and the high granularity of data collected regarding
complications are major strengths of this study. Finally,
another limitation is that if the choice of treatment
modality (segmentectomy vs lobectomy) was driven by
unmeasured patient characteristics that are associated
with the risk of complication, substantial residual
confounding would presist (confounding by indication).
Only a randomized trial comparing the two techniques
would eliminate this potential problem.
Conclusions
In conclusion, we did not observe significant differences in
terms of postoperative complications between intentional
VATS segmentectomies and lobectomies, even after
adjustment for differences in patient characteristics. Both
approaches seem to yield similar rates of complications
and the occurrence of complications depends on the ASA
score and the percentage of the predicted FEV1.
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